Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-7279.25	-76.20	-1.03
Graham Fair Price	41.43	0.74	0.53
PEG	-206.70	-0.02	< 0.005
Price/Book	91.48	0.44	0.23
Price/Cash Flow	-19.39	35.92	44.56
Prices/Earnings	4.26	-1.68	-1.76
Price/Sales	-4.26	0.74	0.77
Price/FCF	-19.39	35.92	44.56
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.03	0.03
Operating Margin	69.97	< 0.005	-0.02
ROA	-100.00	-0.05	-0.03
ROE	-0.03	-0.07	-100.00
ROIC	< 0.005	< 0.005	39.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	1.84	-99.51
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.53	0.40	-24.06
EPS QOQ	-3.19	-1.00	68.78
FCF QOQ	1.13	1.38	21.53
Revenue QOQ	-0.20	1.00	389.90
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	4.26	2.13	-50.00
Days Sales Outstanding (DSO)	45.52	24.07	-47.12
Inventory Turnover	21.14	42.28	100.00
Debt/Capitalization	0.11	0.11	0.66
Quick Ratio	5.01	5.10	1.74
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.61	0.61	< 0.005
Cash	0.22	0.22	< 0.005
Capex	-0.03	-0.06	-100.01
Free Cash Flow	< 0.005	< 0.005	137.54
Revenue	0.18	0.37	100.01
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	6.15	6.15	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	103.40	80.78	-21.87
Naive Interpretation	Member

06 - Financial Health · Bad

Rating